174 related articles for article (PubMed ID: 29360883)
1. Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.
Rodrigues TC; Oliveira MLS; Soares-Schanoski A; Chavez-Rico SL; Figueiredo DB; Gonçalves VM; Ferreira DM; Kunda NK; Saleem IY; Miyaji EN
PLoS One; 2018; 13(1):e0191692. PubMed ID: 29360883
[TBL] [Abstract][Full Text] [Related]
2. Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus.
Rodrigues TC; Figueiredo DB; Gonçalves VM; Kaneko K; Saleem IY; Miyaji EN
J Control Release; 2024 Apr; 368():184-198. PubMed ID: 38395155
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs.
Figueiredo DB; Kaneko K; Rodrigues TDC; MacLoughlin R; Miyaji EN; Saleem I; Gonçalves VM
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745810
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
[TBL] [Abstract][Full Text] [Related]
5. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A.
Castro JT; Oliveira GS; Nishigasako MA; Debrie AS; Miyaji EN; Soares-Schanoski A; Akamatsu MA; Locht C; Ho PL; Mielcarek N; Oliveira MLS
PLoS One; 2020; 15(1):e0228055. PubMed ID: 31945121
[TBL] [Abstract][Full Text] [Related]
8. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments.
Lu J; Guo J; Wang D; Yu J; Gu T; Jiang C; Kong W; Wu Y
Hum Vaccin Immunother; 2019; 15(2):371-380. PubMed ID: 30235046
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
10. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
Oliveira ML; Miyaji EN; Ferreira DM; Moreno AT; Ferreira PC; Lima FA; Santos FL; Sakauchi MA; Takata CS; Higashi HG; Raw I; Kubrusly FS; Ho PL
PLoS One; 2010 May; 5(5):e10863. PubMed ID: 20523738
[TBL] [Abstract][Full Text] [Related]
11. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
Moreno AT; Oliveira ML; Ferreira DM; Ho PL; Darrieux M; Leite LC; Ferreira JM; Pimenta FC; Andrade AL; Miyaji EN
Clin Vaccine Immunol; 2010 Mar; 17(3):439-46. PubMed ID: 20089795
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.
Lima FA; Miyaji EN; Quintilio W; Raw I; Ho PL; Oliveira ML
Vaccine; 2013 May; 31(20):2465-70. PubMed ID: 23541622
[TBL] [Abstract][Full Text] [Related]
13. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.
Xin W; Li Y; Mo H; Roland KL; Curtiss R
Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204
[TBL] [Abstract][Full Text] [Related]
14. A Novel PspA Protein Vaccine Intranasal Delivered by Bacterium-Like Particles Provides Broad Protection Against Pneumococcal Pneumonia in Mice.
Wang D; Lu J; Yu J; Hou H; Leenhouts K; Van Roosmalen ML; Gu T; Jiang C; Kong W; Wu Y
Immunol Invest; 2018 May; 47(4):403-415. PubMed ID: 29498560
[TBL] [Abstract][Full Text] [Related]
15. Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.
Campos IB; Darrieux M; Ferreira DM; Miyaji EN; Silva DA; Arêas AP; Aires KA; Leite LC; Ho PL; Oliveira ML
Microbes Infect; 2008 Apr; 10(5):481-8. PubMed ID: 18403234
[TBL] [Abstract][Full Text] [Related]
16. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
Salcedo-Rivillas C; Debrie AS; Miyaji EN; Ferreira JM; Raw I; Locht C; Ho PL; Mielcarek N; Oliveira ML
Clin Vaccine Immunol; 2014 Jul; 21(7):972-81. PubMed ID: 24807055
[TBL] [Abstract][Full Text] [Related]
17. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
Zhang Y; Guo X; Guo M; Chen X; Li B; Yu J; Gu T; Kong W; Wu Y
Immunol Res; 2019 Oct; 67(4-5):398-407. PubMed ID: 31773490
[TBL] [Abstract][Full Text] [Related]
18. Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against
Wiedinger K; Pinho D; Bitsaktsis C
Ther Adv Vaccines; 2017 Feb; 5(1):15-24. PubMed ID: 28344805
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
20. Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA.
Carneiro GB; Castro JT; Davi M; Miyaji EN; Ladant D; Oliveira MLS
Vaccine; 2023 Jun; 41(28):4170-4182. PubMed ID: 37236818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
